2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
The Global Business News Leader | Saturday, 11 Oct 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
DISCOVERY LABS INC
DSCO (NASDAQ)
$ 1.54 
Change: +0.13 +8.44% | Volume: 1,326,451
Change: +0.13 +8.44% | Volume: 1,326,451
Sponsored by 
DISCOVERY LABS - Fundamental Profile
Company Information
| Ticker Symbol: | DSCO |
|---|---|
| Exchange: | NASD |
| Contact Info: | 2600 Kelley Road Warrington PA 18976-3622 215 488-9300 |
| CEO/President: | Robert J. Capetola Ph.D. |
| Industry: | Medical - Biomedical / Standard Industry Code: 2836 |
| Description: | Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis. |
Share Information
| Shares Outstanding: | 96,690 (000) | Market Value: | 139,380 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 51.08% | Number of Inst.Shareholders: | 13.00% |
| Last Quarter Sales: | 2.50 ($Mil.) | Last Quarter Net Income: | -10.22 ($Mil.) |
| Last Quarter EPS: | -0.11 | P/E Ratio: | 0 |
| Most Recent Earnings: | -0.11 on 08/06/08 | Earnings Per Share: | -0.46 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
DSCO
Companies
IBT
- Ahead of the Bell: Morgan Stanley plunges
- Gold bullion and stocks shine during one of most volatile days
- Harley revs up cooler image with supermodel Miller
- Morgan Stanley shares sink on worries about future
- Harmony leads global gold pack
- Biogen stops work on experimental arthritis drug
- Fed slashes interest rates, but stocks lose again
- W Magazine Angelina Jolie: I bought Maddox his first knife
- Brad Pitts exclusive photos of Angelina Jolie breastfeeding appears on W Magazine Cover
- Sarah Palin is Princess Dianas and Roosevelts distant cousin
- Angelina Jolie: My Twins Are Totally Sweet
- Ahead of Troopergate Report, NYT Says Official Pressured Indirectly
- Playboy Hugh Hefner New Girlfriends: Karissa and Kristina Shannon, Amy Leigh Andrews
- Hugh Heffner: Done With Holly Madison, Moves onto Karissa and Kristina Shannon
Top Competitors
| AMGEN |  |
+14.00 | 58.89 |
| GILEAD SCIENCES |  |
-0.20 | 45.75 |
| GENENTECH INC | |
+16.10 | 87.53 |
| CELGENE CP | |
-14.40 | 60.46 |
| BIOGEN IDEC INC | |
-16.30 | 50.50 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives